Items where Author is "A, Kamarulzaman"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 76.

Article

A, Kamarulzaman (2015) Antibiotic Resistant and Virulence Determinants of Staphylococcus haemolyticus C10A as Revealed by Whole Genome Sequencing. J Genomics, 3. 72–74..

A, Kamarulzaman (2015) Co-infections and transmission networks of HCV, HIV-1 and HPgV among people who inject drugs. Sci Rep, OCT 13.

A, Kamarulzaman (2015) Comparison of genotypic and virtual phenotypic drug resistance interpretations with laboratory- based phenotypes among CRF01_AE and subtype B HIV-infected individuals. J Med. 234-43.

A, Kamarulzaman (2015) Concurrent loss of co-stimulatory molecules and functional cytokine secretion attributes leads to proliferative senescence of CD8(+) T cells in HIV/TB co-infection. Cellular Immunology, 297, ( 1). 19–32.

A, Kamarulzaman (2015) Concurrent loss of co-stimulatory molecules and functional cytokine secretion attributes leads to proliferative senescence of CD8(+) T cells in HIV/TB co-infection. Cellular Immunology, 297, ( 1). 19–32.

A, Kamarulzaman (2015) Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression. J Acquir Immune Defic Synd.

A, Kamarulzaman (2015) Facilitating a transition from compulsory detention of people who use drugs towards voluntary community-based drug dependence treatment and support services in Asia. Harm Reduct J.

A, Kamarulzaman (2015) Genetic Characterization of a Novel HIV-1 Circulating Recombinant Form (CRF74_01B) Identified among Intravenous Drug Users in Malaysia: Recombination History and Phylogenetic Linkage with Previously Defined Recombinant Lineages. PLoS One.

A, Kamarulzaman (2015) Genome Anatomy of Streptococcus parasanguinis Strain C1A, Isolated from a Patient with Acute Exacerbation of Chronic Obstructive Pulmonary Disease, Reveals Unusual Genomic Features. Genome Announc.

A, Kamarulzaman (2015) HIV Prevalence Among People Who Inject Drugs in Greater Kuala Lumpur Recruited Using Respondent-Driven Sampling. AIDS Behav, 19. 2347–2357.

A, Kamarulzaman (2015) High prevalence of non-fatal overdose among people who inject drugs in Malaysia: Correlates of overdose and implications for overdose prevention from a cross-sectional study. Int J Drug Policy. pp. 675-81.

A, Kamarulzaman (2015) Impact of HIV-1 Subtype on the Time to CD4+ T-Cell Recovery in Combination Antiretroviral Therapy (cART)-Experienced Patients. PLoS One.

A, Kamarulzaman (2015) Impact of Gender on Long-Term Treatment Outcomes of Highly Active Antiretroviral Therapy (HAART) in the TREAT Asia HIV Observational Database. AIDS Patient Care STDS. pp. 229-31.

A, Kamarulzaman (2015) Increased frequency of late-senescent T cells lacking CD127 in chronic hepatitis C disease. Eur J Clin Invest. pp. 466-74.

A, Kamarulzaman (2015) Natural killer cell heterogeneity: cellular dysfunction and significance in HIV-1 immuno-pathogenesis. Cell Mol Life Sci. . pp. 3037-49.

A, Kamarulzaman (2015) Prevalence and Correlates of HIV and Hepatitis C Virus Infections and Risk Behaviors among Malaysian Fishermen. PLoS One, AUG 5 (Aug 5).

A, Kamarulzaman (2015) Prevalence and correlates of latent tuberculosis infection among employees of a high security prison in Malaysia. Occup Environ Med. pp. 442-7.

M, Dahlui and A, Kamarulzaman and R, Mohamed (2015) Projections of the Current and Future Disease Burden of Hepatitis C Virus Infection in Malaysia.

A, Kamarulzaman (2015) Risk group characteristics and viral transmission clusters in South-East Asian patients infected with human immunodeficiency virus-1 (HIV-1) circulating recombinant form (CRF) 01_AE and subtype B. The Kaohsiung Journal of Medical Sciences, 31,. Pages 445–453.

A, Kamarulzaman (2015) Tenofovir-based antiretroviral therapy in HBV-HIV coinfection: results from the TREAT Asia HIV Observational Database. Antivir Ther, JUN 12.

A, Kamarulzaman (2015) The syndemic of HIV, HIV-related risk and multiple co- morbidities among women who use drugs in Malaysia: Important targets for intervention. Addictive Behaviors, 53,. Pages 31–39.

A, Kamarulzaman (2015) Transmission Networks of HIV-1 Among Men Who Have Sex With Men in East and Southeast Asia. J Acquir Immune Defic Syndr.

A, Kamarulzaman (2015) Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia. J Subst Abuse Treat, JUL;54. :29-36..

A, Kamarulzaman (2015) Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice. Drug Alcohol Depend. pp. 71-9.

A, Kamarulzaman (2013) Absence of antiretroviral therapy and other risk factors for morbidity and mortality in Malaysian compulsory drug detention and rehabilitation centers. PLOS ONE (7(9)). e44249.

A, Kamarulzaman (2013) Chikungunya infection in Malaysia:Comparison with dengue infection in adults and predictors of persistent arthralgia. J Clin Virol.2012 Nov 29. J Clin Virol. pp. 141-5.

A, Kamarulzaman (2013) Comparisons of Primary HIV-1 Drug Resistance between Recent and Chronic HIV-1 Infection within a Sub- Regional Cohort of Asian Patients. e62057.

A, Kamarulzaman (2013) Evolutionary History of HIV-1 Subtype B and CRF01_AE Transmission Clusters among Men Who Have Sex with Men (MSM) in Kuala Lumpur, Malaysia. PLOS ONE. e67286.

A, Kamarulzaman (2013) Fighting the HIV epidemic in the Islamic world. Lancet. pp. 2058-60.

A, Kamarulzaman (2013) Genome sequence of the hepatitis C virus subtype 6n isolated from malaysia. Genome Announc. (1(1)). e00168-12.

A, Kamarulzaman (2013) High rates of unprotected anal intercourse with regular and casual partners and associated risk factors in a sample of ethnic Malay men who have sex with men (MSM) in Penang, Malaysia. Sex Transm Infect (89(8)). 642-9..

A, Kamarulzaman (2013) Management of tuberculosis and latent tuberculosis infection in human immunodeficiency virus-infected persons. Respirology (18(6)). pp. 912-22.

A, Kamarulzaman (2013) Molecular diversity of HIV-1 among people who inject drugs in Kuala Lumpur, Malaysia: massive expansion of circulating recombinant form (CRF) 33_01B and emergence of multiple unique recombinant clusters. e62560.

A, Kamarulzaman (2013) Molecular signatures of T-cell inhibition in HIV-1 infection. Retrovirology. pp. 10-31.

A, Kamarulzaman (2013) Predictors of death in Malaysian HIV-infected patients on anti-retroviral therapy. Prev Med, 57. Suppl:S54-6.

A, Kamarulzaman (2013) Rates and factors associated with major modifications to first-line combination antiretroviral therapy: results from the Asia-Pacific region. e64902.

A, Kamarulzaman (2013) The diagnostic performance of a single GeneXpert MTB/RIF assay in an intensified tuberculosis case finding survey among HIV-infected prisoners in Malaysia. PLOS ONE.

A, Kamarulzaman (2013) Viral hepatitis and the Global Burden of Disease: a need to regroup. J Viral Hepat (20(9)). pp. 600-1.

S, Abubakar and PS, Hooi and FL, Jafar and A, Kamarulzaman and R, Karunakaran and MY, Mohd Yusof and S,, Ponnampalavanar and SF, Syed Omar (2012) A large exposure to Brucella melitensis in a diagnostic laboratory. pp. 321-5.

A, Kamarulzaman (2012) Absence of antiretroviral therapy and other risk factors for morbidity and mortality in Malaysian compulsory drug detention and rehabilitation centers. PLoS One. 2012;7(9):e44249. doi: 10.1371/journal.pone.0044249. Epub 2012 Sep 18. PLoS One. 2012;7(9):e44249. doi: 10.1371/journal.pone.0044249. Epub 2012 Sep 18..

A, Kamarulzaman (2012) Asian public concern over the ethics of scientists: predictors and implications for research ethics. Account Res, 19(6). pp. 370-82.

A, Kamarulzaman (2012) Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific. Int J Epidemiol, FEB (41(1)). pp. 43-54.

A, Kamarulzaman (2012) Comparison of predicted susceptibility between genotype and virtual phenotype HIV drug resistance interpretation systems among treatment-na HIV- infected patients in Asia: TASER-M cohort analysis. BMC Res Notes. 2012 Oct 24;5(1):582. BMC Res Notes. 2012 Oct 24;5(1):582..

A, Kamarulzaman (2012) EXPANDING ACCESS TO TREATMENT FOR HEPATITIS C IN RESOURCE-LIMITED SETTINGS: LESSONS FROM HIV/AIDS. pp. 1465-72.

A, Kamarulzaman (2012) Evaluating immunologic response and clinical deterioration in treatment-na patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B.

A, Kamarulzaman (2012) FAILURE TO PRESCRIBE PNEUMOCYTIS PROPHYLAXIS IS ASSOCIATED WITH INCREASED MORTALITY, EVEN IN THE cART ERA: RESULTS FROM THE TREAT ASIA HIV OBSERVATIONAL DATABASE. TREAT Asia HIV Observational Database.J Int AIDS Soc. 15(1):1.

A, Kamarulzaman (2012) Genome Sequence of a Novel HIV-1 Circulating Recombinant Form 54_01B from Malaysia. J Virol (86(20)). pp. 11405-6.

A, Kamarulzaman (2012) Genome sequences of a novel HIV-1 CRF53_01B identified in Malaysia. J Virol (86(20)). pp. 11398-9.

A, Kamarulzaman (2012) ISONIAZID PREVENTIVE THERAPY IN CORRECTIONAL FACILITIES: A SYSTEMATIC REVIEW. Int J Tuberc Lung Dis. pp. 871-9.

A, Kamarulzaman (2012) LOSS TO FOLLOWUP IN HIV-INFECTED PATIENTS FROM ASIA- PACIFIC REGION: RESULTS FROM TAHOD. AIDS Res Treat, 375217.

A, Kamarulzaman (2012) PRIORITIZING CD4 COUNT MONITORING IN RESPONSE TO ART IN RESOURCE-CONSTRAINED SETTINGS: A RETROSPECTIVE APPLICATION OF PREDICTION-BASED CLASSIFICATION. PLoS Med. (apr 17).

A, Kamarulzaman (2011) Attitudes toward opioid substitution therapy and pre- incarceration HIV transmission behaviors among HIV- infected prisoners in Malaysia: Implications for secondary prevention. Drug Alcohol Depend.

A, Kamarulzaman (2011) Risk behaviour and HIV prevalence among men who have sex with men in a multiethnic society: a venue-based study in Kuala Lumpur, Malaysia. Int J STD AIDS. 2011 Jan;22(1):30-7. Int J STD AIDS.

A, Kamarulzaman (2011) Robust interferon-¿nd IL-12 responses by dendritic cells are related to efficient CD4(+) T-cell recovery in HIV patients on ART. Clin Immunol.

A, Kamarulzaman (2011) TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease. AIDS.

A, Kamarulzaman (2011) TREAT Asia Studies to Evaluate Resistance- Monitoring Study (TASER-M). HIV-1 drug resistance mutations among antiretroviral-naive HIV-1- infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study.

MY, Fong and A, Kamarulzaman (2011) Zoonotic Brugia pahangi filariasis in a suburbia of Kuala Lumpur City, Malaysia. Parasitology International, 60. pp. 111-113.

A, Kamarulzaman (2010) 12 myths about HIV/AIDS and people who use drugs.

S, Ahmad Sarji and SI, Bux and A, Kamarulzaman and N, M Ramli (2010) CHEST IMAGING FEATURES OF PATIENTS AFFLICTED WITH INFLUENZA A (H1N1) IN A MALAYSIAN TERTIARY REFERRAL CENTRE. BIOMEDICAL IMAGING AND INTERVENTION JOURNAL, 6 (4). e:35.

A, Kamarulzaman (2010) Characteristics of Natural Killer Cells in Malaysian HIV Patients Presenting with Immune Restoration Disease After ART. J AIDS.

A, Kamarulzaman (2010) Evidence for possible biological advantages of the newly emerging HIV-1 circulating recombinant form from Malaysia - CRF33_01B in comparison to its progenitors - CRF01_AE and subtype B.

A, Kamarulzaman (2010) High direct healthcare costs of patients hospitalised with pandemic (H1N1) 2009 influenza in Malaysia. p. 11.

A, Kamarulzaman (2010) Identification of a novel second-generation circulating recombinant form (CRF 48_01B) in Malaysia; a descendant of the previously identified CRF33_01B. J Acquir Immune Defic Syndr 2010 ( In press ).

A, Kamarulzaman (2010) Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD).

A, Kamarulzaman (2010) Time to Act : a call for comprehensive responses to HIV in people who use drugs. Lancet.

A, Kamarulzaman (2010) Treatment of medical, psychiatric, and substance- use comorbidities in people infected with HIV who use drugs. Lancet.

A, Kamarulzaman (2010) Tumour necrosis factor haplotypes associated with sensory neuropathy in Asian and caucasian human immunodeficiency virus patients.

A, Kamarulzaman (2009) Emerging and re-emerging viruses in Malaysia, 1997-2007. pp. 307-18.

A, Kamarulzaman (2009) International Collaboration on Endocarditis Prospective Cohort Study Group. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. pp. 2095-103.

A, Kamarulzaman (2009) International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. pp. 463-73.

A, Kamarulzaman (2009) Lack of reduction in buprenorphine injection after introduction of co- formulated buprenorphine/naloxone to the Malaysian market. Am J Drug Alcohol Abuse., 35 (2). pp. 68-72.

A, Kamarulzaman (2009) Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: The Asia Pacific HIV Observational Database (APHOD). J Acquir Immune Defic Syndr, 50 (5). pp. 513-20.

A, Kamarulzaman (2009) Prospective Cohort Study) Investigators. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med, 150 (9). pp. 586-94.

A, Kamarulzaman (2009) Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database. BMC Infect Dis, 9. p. 46.

A, Kamarulzaman (2009) Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database. Clin Infect Dis, 48 (7). pp. 940-50.

Book Section

A, Kamarulzaman (2008) Public Health Aspects of HIV/AIDS in Developing Countries:Epidemiology, Prevention and Care. In: The HIV epidemic in Malaysia. Springer.

This list was generated on Tue Nov 21 02:14:58 2017 MYT.